Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Molecule Type, By Drug Development Type, By Formulation, By Routes of Administration, By Sales Channel, By Age Group - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global pharmaceutical manufacturing market size was exhibited at USD 502.81 billion in 2022 and is projected to hit around USD 1473.35 billion by 2032, growing at a CAGR of 11.35% during the forecast period 2023 to 2032.

Pharmaceutical Manufacturing Market size

Key Pointers:

  • In 2022, the conventional drugs (small molecules) segment accounted for the highest revenue share of over 75%.
  • Small molecule drugs represent around 65% share in comparison with large molecule drugs.
  • The outsourcing segment dominated the market in 2022 with a revenue share of over 60%. 
  • In terms of revenue, the tablets dominated the market with a share of over 30% in 2022.
  • The oral segment led the global market and was valued at 310.91 billion in 2022. 
  • The other diseases segment dominated the market with a revenue share of more than 69% in 2022 
  • On the other hand, cancer therapies are anticipated to register the fastest CAGR from 2023 to 2032.
  • The prescription medicines segment accounted for the maximum revenue share of 88.73% in 2022 
  • The geriatric segment led the global market and was valued at 303.16 billion in 2022. 
  • The retail segment accounted for the largest revenue share of 80.95% in 2022.
  • North America dominated the market with a share of 39.9% in 2022

The pharmaceutical landscape has undergone a massive transformation with the emergence of new technologies, cost-effective, and more efficient manufacturing approaches. In addition, increasing investment flow in this space has impacted the market growth positively. Manufacturing floor downtime and the production of product waste are reduced by the implementation of robotic technology and Artificial Intelligence (AI). In addition, single-use disposable solutions have gained momentum in this industry and have replaced conventional open transfer manufacturing techniques. Furthermore, the paradigm shift towards integrated, smart, and data-rich paperless operations has resulted in error-free and precise production. Such ongoing developments have propelled drug manufacturing.

The presence of supportive regulatory legislations, patentability norms, and high funding and investments in the pharmaceutical industry are anticipated to drive market growth. In addition, the broadening of preventive care has created significant opportunities in the market.

The high burden of diseases, economic growth leading to a rise in disposable incomes, improvements in healthcare infrastructure, better healthcare financing, and a rise in the geriatric population have spurred the demand for pharmaceutical manufacturing techniques in biotechnology and pharmaceutical companies. These factors have also prompted many individuals to use medications to improve their quality of life and wellness. In addition, the emergence of new pandemics, viruses, and drug-resistant infections has provided potential avenues for pharmaceutical manufacturers to accelerate their drug production.

Several drug developers have shifted their preferences towards continuous manufacturing approaches to minimize production costs, overcome medicine shortages, and improve efficiencies. For instance, in March 2022, CONTINUUS Pharmaceuticals announced the construction of the first GMP facility using continuous manufacturing equipment. The company has received a contract from the U.S. government for the production of finished dosage forms and critical APIs. North America accounted for the highest revenue share in 2032 as the U.S. market represents the largest pharmaceutical industry with a substantial number of drug manufacturers.

Pharmaceutical manufacturing Market Segmentation

By Molecule Type By Drug Development Type By Formulation By Routes of Administration By Therapy Area By Prescription By Age Group By Channel

Biologics & Biosimilars (Large Molecules)

Conventional Drugs (Small Molecules)

 

In-house

Outsource

 

Tablets

Capsules

Injectable

Sprays

Suspensions

Powders

Other Formulations

 

Oral

Topical

Parenteral

Inhalations

Other Routes of Administration

 

Cardiovascular Diseases (CVDs)

Pain

Diabetes

Cancer

Respiratory Diseases

Other Diseases

 

Prescription Medicines

Prescription Medicines

Children & Adolescents

Adults

Geriatric

Retail

Non-retail

Pharmaceutical manufacturing Market Key Players And Regions

Companies Profiled Regions Covered

F. Hoffmann-La Roche Ltd.

Novartis AG

GlaxoSmithKline plc

Pfizer, Inc.; Merck & Co., Inc.

AstraZeneca

Johnson & Johnson

Sanofi SA

Eli Lilly and Company

AbbVie, Inc.

Sun Pharmaceutical Industries Ltd.

Novo Nordisk A/S

Takeda Pharmaceuticals, Inc.

Cipla Ltd.

Bristol Myers Squibb Company

Gilead Sciences, Inc.

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa (MEA)

 

 

Frequently Asked Questions

The global pharmaceutical manufacturing market size was exhibited at USD 502.81 billion in 2022 and is projected to hit around USD 1473.35 billion by 2032, growing at a CAGR of 11.35% during the forecast period 2023 to 2032.

The global pharmaceutical manufacturing market is growing at a compound annual growth rate (CAGR) of 11.35% from 2023 to 2032.

F. Hoffmann-La Roche Ltd.; Novartis AG; GlaxoSmithKline plc; Pfizer, Inc.; Merck & Co., Inc.; AstraZeneca; Johnson & Johnson; Sanofi SA; Eli Lilly and Company; AbbVie, Inc.; Sun Pharmaceutical Industries Ltd.; Novo Nordisk A/S; Takeda Pharmaceuticals, Inc.; Cipla Limited; Bristol Myers Squibb Company; Gilead Sciences, Inc.

Chapter 1. Introduction

                   1.1 Research Methodology

                   1.2 Research Assumptions

                       1.2.1 Estimates And Forecast Timeline

                    1.3 Information Procurement

                       1.3.1 Purchased Database

                       1.3.2 Nova one advisor’s Internal Database

                       1.3.3 Secondary Sources

                       1.3.4 Primary Research

                       1.3.5 Details Of Primary Research

                   1.4 Information or Data Analysis

                       1.4.1 Data Analysis Models

                   1.5 Market Formulation & Validation

                   1.6 Model Details

                       1.6.1 Commodity Flow Analysis

                           1.6.1.1 Country wise market estimation using bottom up approach

                   1.7 Global Market: CAGR Calculation

                   1.8 List of Secondary Sources

                   1.9 List of Primary Sources

                   1.10 Objectives

                       1.10.1 Objective 1:

                       1.10.2 Objective 2:

Chapter 2 Executive Summary

                   2.1 Pharmaceutical Manufacturing Market: Market Outlook

                   2.2 Pharmaceutical Manufacturing Market: Market Segmentation

                   2.3 Pharmaceutical Manufacturing Market: Competitive Insights

                   2.4 Market Summary

Chapter 3 Market Variables, Trends & Scope

                   3.1 Penetration & Growth Prospect Mapping for Route of Administration, 2020

                   3.2 Pharmaceutical Manufacturing: Pipeline Analysis

                   3.3 Pharmaceutical Manufacturing: Medicine Usage and Spending

                   3.4 Pharmaceutical Manufacturing Market: Impact of COVID-19 Infection

                       3.4.1 Effects On Supply Chain

                       3.4.2 Distribution And Logistics Concerns

                       3.4.3 Pharma Research Into COVID-19

                   3.5 Pharmaceutical Manufacturing: Regulatory Framework

                       3.5.1 Regulatory Framework In the U.S.

                       3.5.2 Regulatory Framework in the Europe

                       3.5.3 Regulatory Framework in China

                       3.5.4 Regulatory Framework in India

                       3.5.5 Regulatory Framework in Brazil

                   3.6 Market Dynamics

                       3.6.1 Market Driver Analysis

                           3.6.1.1 Rise in pharmaceutical R&D spending

                           3.6.1.2 Advancements in pharmaceutical manufacturing technologies

                           3.6.1.3 Rise in focus toward healthcare needs IN emerging nations

                           3.6.1.4 increase in geriatric population and incidence of chronic disorders

                       3.6.2 Market Restraint Analysis

                           3.6.2.1 Patent expiration of most profitable drugs

                           3.6.2.2 Pricing pressures on bio/pharmaceutical companies

                       3.6.3 Market Challenge Analysis

                           3.6.3.1 Challenges pertaining pharma supply chain

                           3.6.3.2 Lack of skilled professionals

                       3.6.4 Market Opportunity Analysis

                           3.6.4.1 Increase in number of clinical trials

                           3.6.4.2 increasing Investment and funding programs in pharmaceutical manufacturing industry

                   3.7 Business Environment Analysis

                       3.7.1 Pharmaceutical Manufacturing Market: Swot Analysis; By Factor (Political & Legal, Economic, And Technological)

                       3.7.2 Porter’s Five Forces Analysis

                   3.8 Market Strategic Alliances

                       3.8.1 Agreement

                       3.8.2 Merger & acquisition

                       3.8.3 Partnership & collaboration

                   3.9 Market Entry Strategies

                       3.9.1 Entry strategies

                       3.9.2 Market entry strategies for small and mid-sized companies

Chapter 4 Molecule Type Business Analysis

                   4.1 Pharmaceutical Manufacturing Market: Molecule Type Movement Analysis

                   4.2 Biologics & Biosimilars (Large Molecules)

                       4.2.1 Global biologics & biosimilars (large molecules) manufacturing market, 2018 - 2032 

                   4.3 Conventional Drugs (Small Molecules)

                       4.3.1 Global conventional drugs (small molecules) manufacturing market, 2018 - 2032 

Chapter 5 Drug Development Type Business Analysis

                   5.1 Pharmaceutical Manufacturing Market: Drug Development Type Movement Analysis

                   5.2 In-house

                       5.2.1 Global in-house pharmaceutical manufacturing market, 2018 - 2032 

                   5.3 Outsource

                       5.3.1 Global outsource pharmaceutical manufacturing market, 2018 - 2032 

Chapter 6 Formulation Business Analysis

                   6.1 Pharmaceutical Manufacturing Market: Formulation Movement Analysis

                   6.2 Tablets

                       6.2.1 Global pharmaceutical manufacturing market for tablets, 2018 - 2032 

                   6.3 Capsules

                       6.3.1 Global pharmaceutical manufacturing market for capsules, 2018 - 2032 

                   6.4 Injectable

                       6.4.1 Global pharmaceutical manufacturing market for injectable, 2018 - 2032 

                   6.5 Sprays

                       6.5.1 Global pharmaceutical manufacturing market for sprays, 2018 - 2032 

                   6.6 Suspensions

                       6.6.1 Global pharmaceutical manufacturing market for suspensions, 2018 - 2032 

                   6.7 Powders

                       6.7.1 Global pharmaceutical manufacturing market for powders, 2018 - 2032 

                   6.8 Other Formulations

                       6.8.1 Global pharmaceutical manufacturing market for other formulations, 2018 - 2032 

Chapter 7 Routes Of Administration Business Analysis

                   7.1 Pharmaceutical Manufacturing Market: Routes of Administration Movement Analysis

                   7.2 Oral

                       7.2.1 Global pharmaceutical manufacturing market for oral route of administration, 2018 - 2032 

                   7.3 Topical

                       7.3.1 Global pharmaceutical manufacturing market for topical route of administration, 2018 - 2032 

                   7.4 Parenteral

                       7.4.1 Global pharmaceutical manufacturing market for parenteral route of administration, 2018 - 2032 

                   7.5 Inhalations

                       7.5.1 Global pharmaceutical manufacturing market for inhalations route of administration, 2018 - 2032 

                   7.6 Other Routes of Administration

                       7.6.1 Global pharmaceutical manufacturing market for other route of administration, 2018 - 2032 

Chapter 8 Therapy Area Business Analysis

                   8.1 Pharmaceutical Manufacturing Market: Therapy Area Movement Analysis

                   8.2 Cardiovascular Diseases

                       8.2.1 Global pharmaceutical manufacturing market for cardiovascular diseases, 2018 - 2032 

                   8.3 Pain

                       8.3.1 Global pharmaceutical manufacturing market for pain, 2018 - 2032 

                   8.4 Diabetes

                       8.4.1 Global pharmaceutical manufacturing market for diabetes, 2018 - 2032 

                   8.5 Cancer

                       8.5.1 Global pharmaceutical manufacturing market for cancer, 2018 - 2032 

                   8.6 Respiratory Diseases

                       8.6.1 Global pharmaceutical manufacturing market for respiratory diseases, 2018 - 2032 

                   8.7 Other Diseases

                       8.7.1 Global pharmaceutical manufacturing market for other diseases, 2018 - 2032 

Chapter 9 Prescription Business Analysis

                   9.1 Pharmaceutical Manufacturing Market: Prescription Movement Analysis

                   9.2 Prescription Medicines

                       9.2.1 Global pharmaceutical manufacturing market for prescription medicines, 2018 - 2032 

                   9.3 Over-the-Counter (OTC) Medicines

                       9.3.1 Global pharmaceutical manufacturing market for otc medicines, 2018 - 2032 

Chapter 10 Age Type Business Analysis

                   10.1 Pharmaceutical Manufacturing Market: Age Type Movement Analysis

                   10.2 Children & Adolescents

                       10.2.1 Global pharmaceutical manufacturing market for children & adolescents, 2018 - 2032 

                   10.3 Adults

                       10.3.1 Global pharmaceutical manufacturing market for adults, 2018 - 2032 

                   10.4 Geriatric

                       10.4.1 Global pharmaceutical manufacturing market for geriatric, 2018 - 2032 

Chapter 11 Sales Channel Business Analysis

                   11.1 Pharmaceutical Manufacturing Market: Sales Channel Movement Analysis

                   11.2 Retail

                       11.2.1 Global pharmaceutical manufacturing market for retail channels, 2018 - 2032 

                   11.3 Non-retail

                       11.3.1 Global pharmaceutical manufacturing market for non-retail, 2018 - 2032 

Chapter 12 Regional Business Analysis

                   12.1 Pharmaceutical Manufacturing Market: Regional Movement Analysis

                   12.2 North America

                       12.2.1 North America Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2032 

                       12.2.2 The U.S.

                           12.2.3.1 The U.S. pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.2.3.2 The U.S. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.2.3.3 The U.S. pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.2.3.4 The U.S. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.2.3.5 The U.S. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.2.3.6 The U.S. pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.2.3.7 The U.S. pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.2.3.8 The U.S. pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.2.3 Canada

                           12.2.3.1 Canada pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.2.3.2 Canada pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.2.3.3 Canada pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.2.3.4 Canada pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.2.3.5 Canada pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.2.3.6 Canada pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.2.3.7 Canada pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.2.3.8 Canada pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                   12.3 Europe

                       12.3.1 Europe Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2032 

                       12.3.2 Germany

                           12.3.2.1 Germany pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.3.2.2 Germany pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.3.2.3 Germany pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.3.2.4 Germany pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.3.2.5 Germany pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.3.2.6 Germany pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.3.2.7 Germany pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.3.2.8 Germany pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.3.3 The U.K.

                           12.3.3.1 The U.K. pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.3.3.2 The U.K. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.3.3.3 The U.K. pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.3.3.4 The U.K. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.3.3.5 The U.K. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.3.3.6 UK pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.3.3.7 The U.K. pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.3.3.8 The U.K. pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.3.4 France

                           12.3.4.1 France pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.3.4.2 France pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.3.4.3 France pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.3.4.4 France pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.3.4.5 France pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.3.4.6 France pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.3.4.7 France pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.3.4.8 France pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.3.5 Spain

                           12.3.5.1 Spain pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.3.5.2 Spain pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.3.5.3 Spain pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.3.5.4 Spain pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.3.5.5 Spain pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.3.5.6 Spain pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.3.5.7 Spain pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.3.5.8 Spain pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.3.6 Italy

                           12.3.6.1 Italy pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.3.6.2 Italy pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.3.6.3 Italy pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.3.6.4 Italy pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.3.6.5 Italy pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.3.6.6 Italy pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.3.6.7 Italy pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.3.6.8 Italy pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                   12.4 Asia Pacific

                       12.4.1 Asia Pacific Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2032 

                       12.4.2 Japan

                           12.4.2.1 Japan pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.4.2.2 Japan pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.4.2.3 Japan pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.4.2.4 Japan pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.4.2.5 Japan pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.4.2.6 Japan pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.4.2.7 Japan pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.4.2.8 Japan pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.4.3 China

                           12.4.3.1 China pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.4.3.2 China pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.4.3.3 China pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.4.3.4 China pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.4.3.5 China pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.4.3.6 China pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.4.3.7 China pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.4.3.8 China pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.4.4 India

                           12.4.4.1 India pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.4.4.2 India pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.4.4.3 India pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.4.4.4 India pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.4.4.5 India pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.4.4.6 India pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.4.4.7 India pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.4.4.8 India pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                   12.5 Latin America

                       12.5.1 Latin America Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2032 

                       12.5.2 Brazil

                           12.5.2.1 Brazil pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.5.2.2 Brazil pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.5.2.3 Brazil pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.5.2.4 Brazil pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.5.2.5 Brazil pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.5.2.6 Brazil pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.5.2.7 Brazil pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.5.2.8 Brazil pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.5.3 Mexico

                           12.5.3.1 Mexico pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.5.3.2 Mexico pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.5.3.3 Mexico pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.5.3.4 Mexico pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.5.3.5 Mexico pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.5.3.6 Mexico pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.5.3.7 Mexico pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.5.3.8 Mexico pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                   12.6 Middle East and Africa (MEA)

                       12.6.1 Mea Pharmaceutical Manufacturing Market Estimates And Forecast, 2018 - 2032 

                       12.6.2 South Africa

                           12.6.2.1 South Africa pharmaceutical manufacturing market estimates and forecast, by molecule type, 2018 - 2032 

                           12.6.2.2 South Africa pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.6.2.3 South Africa pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.6.2.4 South Africa pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.6.2.5 South Africa pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.6.2.6 South Africa pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.6.2.7 South Africa pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.6.2.8 South Africa pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

                       12.6.3 Saudi Arabia

                           12.6.3.1 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by molecule type,2018 - 2032 

                           12.6.3.2 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by drug development type, 2018 - 2032 

                           12.6.3.3 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by formulation, 2018 - 2032 

                           12.6.3.4 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by route of administration, 2018 - 2032 

                           12.6.3.5 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by therapy area, 2018 - 2032 

                           12.6.3.6 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by prescription requirement, 2018 - 2032 

                           12.6.3.7 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by age type, 2018 - 2032 

                           12.6.3.8 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by sales channel, 2018 - 2032 

Chapter 13 Competitive Landscape

                   13.1 Recent Developments & Impact Analysis, by Key Market Participants

                   13.2 Public Companies

                       13.2.1 Top pharmaceutical companies

                   13.3 Private Companies

                       13.3.1 List of key emerging companies

                   13.4 Strategy Framework

                   13.5 Market Participation Categorization

                   13.6 Company Profiles

                       13.6.1 ASTRAZENECA

                           13.6.1.1 Company overview

                           13.6.1.2 Financial performance

                           13.6.1.3 Product benchmarking

                           13.6.1.4 Strategic initiatives

                       13.6.2 F. HOFFMANN-LA ROCHE LTD.

                           13.6.2.1 Company overview

                           13.6.2.2 Financial performance

                           13.6.2.3 Product benchmarking

                           13.6.2.4 Strategic initiatives

                       13.6.3 THERMO FISHER SCIENTIFIC, INC.

                           13.6.3.1 Company overview

                           13.6.3.2 Patheon

                               13.6.3.2.1 Company overview

                               13.6.3.2.2 DPx

                           13.6.3.3 Brammer Bio

                               13.6.3.3.1 Company overview

                           13.6.3.4 Financial performance

                               13.6.3.4.1 Financial performance

                           13.6.3.5 Product benchmarking

                           13.6.3.6 Strategic initiatives

                       13.6.4 WUXI APPTEC

                           13.6.4.1 Company overview

                           13.6.4.2 Wuxi Advanced Therapies

                               13.6.4.2.1 Company Overview

                           13.6.4.3 Financial performance

                           13.6.4.4 Product benchmarking

                           13.6.4.5 Strategic initiatives

                       13.6.5 SAMSUNG BIOLOGICS

                           13.6.5.1 Company overview

                           13.6.5.2 Financial performance

                           13.6.5.3 Product benchmarking

                           13.6.5.4 Strategic initiatives

                       13.6.6 FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.

                           13.6.6.1 Company overview

                           13.6.6.2 Product benchmarking

                           13.6.6.3 Strategic initiatives

                       13.6.7 LONZA

                           13.6.7.1 Company overview

                           13.6.7.2 Financial performance

                           13.6.7.3 Product benchmarking

                           13.6.7.4 Strategic initiatives

                       13.6.8 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC

                           13.6.8.1 Company overview

                           13.6.8.2 Financial performance

                           13.6.8.3 Product benchmarking

                           13.6.8.4 Strategic initiatives

                       13.6.9 CATALENT PHARMA SOLUTIONS

                           13.6.9.1 Company overview

                           13.6.9.2 Financial performance

                           13.6.9.3 Product benchmarking

                           13.6.9.4 Strategic initiatives

                       13.6.10 JUBILANT LIFE SCIENCES LIMITED

                           13.6.10.1 Company overview

                           13.6.10.2 Financial performance

                           13.6.10.3 Product benchmarking

                           13.6.10.4 Strategic initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert